June 27, 2026 08:56 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ram Mandir Trust chief Champat Rai resigns as alleged donation siphoning row escalates | Ram Mandir fund row deepens: 8 arrested days after BJP called allegations 'false narrative' | 'Who tied the hands of CBI?': Calcutta HC on RG Kar case; victim's mother, now BJP MLA, says she is 'deeply disturbed' | Construction comes to a standstill at nearly 700 Kolkata projects after Taratala warehouse tragedy kills 15 | World Cup shocker! Ecuador stun Germany 2-1, storm into Round of 32 | Iran-US conflict: Cargo vessel hit near Strait of Hormuz, UN agency pauses evacuation operations | Amazon's massive India bet! Andy Jassy announces $48 billion investment after meeting PM Modi | Taratala warehouse collapse: Death toll climbs to 8, five arrested as SIT launches probe | Oil prices crash, IndiGo takes off! Aviation and fuel stocks emerge as biggest winners | Passport is a travel document, not conclusive proof of citizenship: MEA

Dexamethasone proves life-saving drug for COVID-19 patients: UK experts

| @indiablooms | Jun 16, 2020, at 08:15 pm

London/IBNS: Amid the deteriorating condition worldwide, experts in the United Kingdom have suggested that treating Coronavirus patients with low doses of the generic steroid drug dexamethasone have been effective in reducing death rates.

According to new trial data published on Tuesday, the drug had reduced death rates by around one-third among those having the most severe conditions due to the infection.

Experts have termed it a 'major breakthrough' in the fight against the deadly virus.

"It cut the risk of death by a third for patients on ventilators. For those on oxygen, it cut deaths by a fifth," a BBC report said.

The drug had been a part of experiments to examine if it worked for coronavirus treatments.

Researchers noted that had the drug been used since the inception of the pandemic in the UK, up to 5000 lives could have been saved.

The drug has a huge potentiality to treat patients in poor countries owing to its cheap price and wide availability.

The UK is the fifth worst-hit country globally with nearly 3 lakh cases and about 42,000 deaths.



 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.